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Cell cycleAbstract The hepatocellular carcinoma, a primary malignancy of the liver, has a very poor prog-
nosis and a lower survival rate. Moreover, the inefficacy of conventional therapies emphasizes the
importance of discovering new bioactive compounds. Several studies clearly state that plant-derived
polyphenols, namely ellagitannins, have several health benefits. Fragaria vesca leaves contain high
amounts of polyphenols, being especially rich in ellagitannins. Therefore, this study aimed to char-
acterize an ellagitannin-enriched fraction (EEF) from F. vesca leaves and to unveil the anticancer
potential of this fraction on human hepatocellular carcinoma cells.a leaves.
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Arabian Journal of Chemistry (2015), http:/The analysis of EEF by HPLC-PDA-ESI/MSn allowed the detection of 12 ellagitannins. The cell
viability of both EEF and crude extract was determined after 24 h of cells treatment and the half-
maximal inhibitory concentration (IC50) was evaluated. The IC50 of the EEF (113 lg/mL) was
about 6 times lower than the IC50 of the crude extract (690 lg/mL). Furthermore, EEF induced cell
cycle arrest at G2/M checkpoint and decreased cell proliferation in a dose-dependent way. This
fraction also induced an accumulation of LC3-II protein through blockage of autophagic flux,
and inhibited chymotrypsin-like activity of 26S proteasome. These results showed, for the first time,
that EEF from F. vesca leaves inhibits both, autophagic and ubiquitin-proteasome system path-
ways, two main intracellular protein degradation systems that are targets for anticancer therapies.
Additionally, a proteomic analysis allowed the identification of 914 proteins, among which 133 were
modulated after cells treatment with EEF, most of them related to metabolic pathways. Overall, this
study shows that the EEF from F. vesca leaves decreased cell proliferation, inhibited the proteolytic
mechanisms and modulated the metabolic pathways of the cell. Additionally this study points out F.
vesca as a source of valuable molecules with anticancer potential, suggesting that ellagitannins, the
polyphenols identified in this fraction, could be useful in the development of new fine-tuned thera-
peutic strategies against carcinogenesis.
 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Liver cancer is the sixth most frequent neoplasia and the third cause of
cancer-related death worldwide (Center and Jemal, 2011). Hepatocel-
lular carcinoma accounts for between 85% and 90% of primary liver
cancers and generally occurs in patients with underlying chronic liver
disease, especially with chronic hepatitis B virus (El-Serag and
Rudolph, 2007). Hepatocellular carcinoma has a very poor prognosis
because diagnosis is usually made at an advanced stage, when treat-
ment options are limited and less effective (Lin et al., 2012). Therefore,
the discovery of new bioactive molecules to overcome the inefficacy
and the side effects of conventional therapies is still a hotspot of anti-
cancer research.
Cancer cells are characterized by unbalanced control of cellular
proliferation and an immortalized life span (Feitelson et al., 2015).
Accordingly, any molecule capable of suppressing cancer cell prolifer-
ation may be valuable as a potential chemopreventive/chemotherapeu
tic agent. Several polyphenols have shown the capacity to block the ini-
tiation of the carcinogenic process and to suppress both promotion
and progression of cancer (Ramos, 2008). Apart from the well-
known antioxidant properties of polyphenols, their role on cell growth
(Kampa et al., 2007), apoptosis (Fresco et al., 2010) and cell prolifer-
ation (Giovannini and Masella, 2012) is also well established, being
those effects usually cell type- and dose-dependent.
Ellagitannins (hydrolysable tannins) are bioactive polyphenols
composed by moieties of hexahydroxydiphenoyl (HHDP) esterified
to a sugar, usually the glucose, that release ellagic acid upon hydrolysis
(Aguilera-Carbo et al., 2008). They are distributed in the plant king-
dom (Okuda et al., 1993) and are commonly found in herbal prepara-
tions (Quideau, 2009), fruits (Aaby et al., 2007) and beverages (Lee and
Talcott, 2002). Multiple biological activities have been ascribed to
ellagitannins, namely antioxidant, anti-atherosclerotic, anti-
inflammatory and anti-viral (Ascacio-Valdes et al., 2011). Further-
more, there is a wealth of information indicating the potent anticancer
activities of ellagitannins (Auzanneau et al., 2012; Sartippour et al.,
2008). Accordingly, some ellagitannins demonstrated to inhibit cell
proliferation, which was in part due to their ability to arrest cell cycle
(Cho et al., 2015; Vassallo et al., 2013). Additionally, these molecules
have been shown to induce apoptotic cell death in different cell lines,
modulating several molecular pathways and the expression of apop-
totic regulators (Li et al., 2013; Wang et al., 2013).
Fragaria vesca L., commonly known as wild strawberry, is an
herbaceous perennial plant that is primarily valued for their fruits,
the strawberries. However, the leaf has a great pharmacologicalet al., Chemical characterization and cyt
/dx.doi.org/10.1016/j.arabjc.2015.11.014potential considering its traditional uses (Camejo-Rodrigues et al.,
2003; Neves et al., 2009) and the presence of high amounts of bioactive
compounds (Buricova et al., 2011; Ivanov et al., 2015). In fact, our
group previously demonstrated that a crude extract obtained from F.
vesca L. was enriched in polyphenols, namely ellagitannins, proantho-
cyanidins, and quercetin and kaempferol glucuronide derivatives,
being ellagitannins the main phenolic compounds. In addition, we
proved that this extract modulated the activity of the proteolytic mech-
anisms of the cells, the ubiquitin-proteasome system (UPS) and
autophagy-lysosomal system (Liberal et al., 2014). These processes
are responsible for the degradation of dysfunctional and damaged cel-
lular components and their dysregulation is implicated in wide range of
pathological conditions (Vilchez et al., 2014). Moreover, given their
association with the carcinogenic process, these proteolytic pathways
constitute privileged targets for anticancer therapies (Driscoll and
Chowdhury, 2012).
In this study, we aimed to obtain an ellagitannin-enriched fraction
(EEF) from the crude extract previously reported and to further
explore the molecular mechanisms behind EEF bioactivity. Briefly,
the polyphenols of this fraction were characterized and its cytotoxic
effect on human hepatocellular carcinoma cells (HepG2) was evalu-
ated. Then, we investigated the effect of EEF on cell proliferation, cell
cycle and cell death, as well as its effect in the proteolytic mechanisms.
Furthermore, a proteomic based approach was used to disclose differ-
entially expressed proteins following cell treatment with this fraction,
evaluating the main cellular processes modulated by EEF.
2. Material and methods
2.1. Materials
Fetal calf serum was obtained from GIBCO (Paisley, UK).
Protease and phosphatase inhibitor cocktail tablets were
acquired from Roche (Basel, Switzerland). Polyvinylidene flu-
oride (PVDF) membranes were obtained from Millipore Iber-
ica (Madrid, Spain) and acrylamide from BioRad (Hercules,
CA, USA). The following antibodies were used: anti-
ubiquitin, clone P4D1 (Biolegend, San Diego, CA, USA),
anti-microtubule-associated protein light chain 3 (LC3) (Cell
Signaling Technologies, Danvers, MA, USA), anti-insulin-
like growth factor-binding protein 1 (IGFBP1) (Abcam, Cam-
bridge, UK), anti-fatty acid synthase (FAS) (Cell Signalingotoxic potential of an ellagitannin-enriched fraction from Fragaria vesca leaves.
Chemical characterization and cytotoxic potential of an ellagitannin-enriched fraction 3Technologies, Danvers, MA, USA), and anti-b-tubulin anti-
body (Sigma Chemical Corporation, St. Louis, MO, USA).
Enhanced chemifluorescence (ECF) substrate, anti-mouse
and anti-rabbit alkaline phosphatase-conjugated secondary
antibodies were purchased from GE Healthcare (Chalfont St.
Giles, UK). Suc-Leu-Leu-Val-Tyr-AMC (Suc-LLVY-AMC)
was from Enzo Life Sciences (Farmingdale, NY, USA).
Click-iT EdU Alexa Fluor 488 Flow Cytometry Assay
Kit was obtained from Molecular Probes, Invitrogen (Eugene,
OR, USA) and propidium iodide (PI) with RNase solution and
annexin V-fluorescein isothiocyanate (FITC)/PI from
Immunostep (Salamanca, Spain). All other reagents were
acquired from Sigma Chemical Corporation (St. Louis, MO,
USA) and Merck (Darmstadt, Germany).
2.2. Plant material
F. vesca wild plants (with flowers and fruits) were sustainably
collected from Granja de Figueira do Lorva˜o, Penacova, Por-
tugal (May, 2011). A voucher specimen (ID-180611) was
deposited at the Herbarium of Medicinal Plants, Faculty of
Pharmacy, University of Coimbra.
The leaves were separated from stems, flowers and fruits
and dried in a drying oven during 24 h, at 30 C with forced
air circulation. They were powdered and sieved before
extraction.
2.3. Extract fractionation
A hydroalcoholic extract from F. vesca leaves was prepared as
previously described (Liberal et al., 2014). Briefly the dry and
powdered leaves were treated with dichloromethane (2 times)
and the extraction was performed with ethanol (2 times) and
50% aqueous ethanol (3 times) at room temperature using
an Ultra-Turrax homogenizer for 5 min at 8000–9500 rpm.
The ethanol and hydroalcoholic extracts were combined and
concentrated on a rotatory evaporator to a small volume
and lyophilized. This extract was stored at 20 C until the
time for testing.
The lyophilized extract (3 g) was recovered with 50% aque-
ous methanol and fractionated by gel chromatography on a
Sephadex LH-20 (Sigma-Aldrich) column (25 cm  5 cm)
by elution successively with 50% (2 L) and 75% aqueous
methanol (2.5 L) and 70% aqueous acetone (1 L).
All the fractionation process was monitored by high-
performance liquid chromatography (HPLC) providing 8
major fractions: F1 (174 mL; phenolic acids), F2 (320 mL;
phenolic acids and flavonoids;), F3 (710 mL; flavonoids), F4
(1198 mL; gallotannins and ellagic acid), F5 (704 mL; proan-
thocyanidins and ellagic acid), F6 (1087 mL; proanthocyani-
dins and ellagic acid), F7 (383 mL; proanthocyanidins) and
F8 (946 mL; ellagitannins). The polyphenol-rich fractions were
then taken to dryness under reduced pressure on a rotatory
evaporator, at 40 C, lyophilized and weighted in sterilized
and humidity-controlled conditions.
Since ellagitannins were one of the main phenolic com-
pounds of the hydroalcoholic extract, an EEF was selected
to evaluate the effect of these polyphenols in the hepatocellular
carcinoma cell line. Ellagitannins were only identified in this
fraction, which was obtained with 70% aqueous acetone (yield
of 14% of 100 g of the F. vesca extract). The yields of thePlease cite this article in press as: Liberal, J. et al., Chemical characterization and cyt
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19%, F3 – 8%, F4 – 3%, F5 – 3%, F6 – 3% and F7 – 1%.
2.4. HPLC-PDA-ESI/MSn analysis
Polyphenols structural identification of EEF was carried out
on a Surveyor liquid chromatograph equipped with a PDA
detector (Surveyor) and interfaced with a Finnigan LCQ
Advantage Ion Max MSn mass spectrometer (Thermo Fisher
Scientific) equipped with an API-ES ionization chamber.
Separation occurred on a Spherisorb ODS-2 column
(150  2.1 mm i.d.; particle size, 3 lm; Waters Corp.) and
a Spherisorb ODS-2 guard cartridge (10  4.6 mm i.d.; par-
ticle size, 5 lm; Waters Corp.) at 25 C, using 2% aqueous
formic acid (v/v) (A) and methanol (B) as mobile phase.
The gradient profile was 5–15% B (0–10 min), 15–25% B
(10–15 min), 25–50% B (15–50 min), 50–80% B (50–
60 min), 80–100% B (60–70 min) and an isocratic elution
for 5 min, at a flow rate of 200 lL min1. The first detection
was performed on PDA detector in a wavelength range 200–
450 nm, followed by a second detection in the mass spec-
trometer. Mass spectra were acquired in negative ion mode.
The mass spectrometer was programmed to perform four
consecutive scans: full mass (m/z 125–2000), MS2 of the
most abundant ion in the full mass, MS3 of the most abun-
dant ion in the MS2 and MS4 of the most abundant ion in
the MS3. Source voltage was 4.7 kV and the capillary volt-
age and temperature were 7 V and 275 C, respectively.
Nitrogen was used as sheath and auxiliary gas at 20 and 7
Finnigan arbitrary units, respectively. The normalized energy
of collision was 49%, using helium as collision gas. Data
treatment was carried out with XCALIBUR software
(Thermo Scientific).
2.5. Cell culture
Human hepatic carcinoma cell line (HepG2 – ATCC HB-8065)
was kindly supplied by Professor Conceic¸a˜o Pedroso Lima
(Center for Neurosciences and Cell Biology, University of
Coimbra, Portugal) and cultured in Dulbecco’s Modified Eagle
Medium (DMEM) containing 10% (v/v) heat-inactivated fetal
bovine serum, 100 U/mL penicillin, and 100 lg/mL strepto-
mycin. Cells were maintained at 37 C and 5%CO2 in a humid-
ified incubator.
2.6. Assessment of cell viability
The effect of EEF on cell viability/metabolic activity was evalu-
ated by resazurin assay (O’Brien et al., 2000).Cells (8  104 cells/
well) were plated in 96-well plates, in duplicates, for 12 h and
incubated with serial concentrations of EEF for 24 h. Resazurin
(50 lM)was added to the cells 1 h before recording fluorescence.
Absorbance was recorder at 570 nm, with a reference wave-
length of 620 nm, using a standard spectrophotometer (SLT,
Austria). In this assay, metabolic active cells reduce resazurin
(blue dye) into resorufin (pink colored); therefore, their number
correlates with the magnitude of dye reduction. Cell viability
was evaluated based on a comparison with untreated cells. The
half-maximal inhibitory concentration (IC50) represents the
EEF concentration required to inhibit 50% of cell viability
and was determined by nonlinear regression.otoxic potential of an ellagitannin-enriched fraction from Fragaria vesca leaves.
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Cells (6.4  105) were plated in 12-well plates. HepG2 prolifer-
ation was assessed by incorporation of 5-ethynyl-20-
deoxyuridine (EdU), a thymidine analog that is incorporated
into DNA of dividing cells during S phase. Cells were treated
with different concentrations of EEF for 24 h and EdU
(10 lM) was added 3 h before cell fixation with 70% aqueous
ethanol. Click-iT EdU Alexa Fluor 488 Flow Cytometry
Assay Kit was performed according to the manufacturer’s
instructions (Molecular Probes, Invitrogen).
Cell cycle distribution was analyzed after 24 and 48 h of
EEF addition. Cells were harvested by trypsinization, washed
twice and fixed with 70% ice-cold aqueous ethanol overnight
and then incubated with PI with RNase solution for 15 min
at room temperature before analysis.
After cells incubation for 24 h with EEF, apoptosis was
detected using an annexin V-fluorescein isothiocyanate
(FITC)/PI double staining, as described by the supplier
(Immunostep).
All the flow cytometry measurements were performed on a
Becton Dickinson FACSCalibur cytometer using the Cellquest
software (BD Biosciences). PI histogram modeling was per-
formed in ModFit LT software (Verity Software House).
The flow cytometer was calibrated with fluorescent standard
microbeads (CaliBRITE Beads; BD Biosciences) for accurate
instrument setting.2.8. Morphological analysis with May-Gru¨nwald-Giemsa and
Hoechst 33258
After 24 h of EEF treatment cells were trypsinized, resus-
pended in 30 ll of FBS and placed on a slide for micro-
scopic analysis. The cells were stained for 3 min with May-
Gru¨nwald solution (0.3% v/v in methanol, then diluted in
distilled water at 1:1 (v/v) ratio) and finally incubated during
15 min with Giemsa solution (0.75% w/v in glycerol/metha-
nol 1:1) previously diluted in distilled water (8). Cells were
rinsed with distilled water and then left to dry at room
temperature. Cell morphology was analyzed by light micro-
scopy using an Olympus BX51TF microscope (Olympus
Co. Ltd.)
For nuclear Hoechst-33258 staining cells were plated in
8-well chambered slides. After 24 h of treatment with EEF,
cells were washed with PBS and fixed with 4% paraformalde-
hyde for 10 min, washed with PBS and incubated with 5 lg/
mL Hoechst 33258 for 5 min at room temperature. Nuclear
morphology was visualized under a fluorescence microscope
(Leica DM4000B, Leica Microsystems).2.9. Western blot analysis
Protein samples preparation, quantification and western blot
were performed as previously described (Liberal et al., 2014).
The antibodies were used in the following concentrations:
anti-ubiquitin, clone P4D1 (1:2000), anti-LC3 (1:1000),
anti-IGFBP1 (1:1000), anti-FAS (1:1000), anti-b-tubulin
(1:20,000), and anti-mouse and anti-rabbit alkaline
phosphatase-conjugated secondary antibodies (1:20,000).Please cite this article in press as: Liberal, J. et al., Chemical characterization and cyt
Arabian Journal of Chemistry (2015), http://dx.doi.org/10.1016/j.arabjc.2015.11.0142.10. Proteasome chymotrypsin-like activity
HepG2 cells were lysed in 50 mM Tris–HCl buffer (pH 7.6)
containing 1 mM dithiothreitol and 2 mM of adenosine
triphosphate (ATP). Equal amounts of protein were incubated
with the proteasome substrate (fluorogenic) Suc-Leu-Leu-Val-
Tyr-AMC (Suc-LLVY-AMC). Enzymatic kinetic was mea-
sured, during 30 min, in a temperature-controlled microplate
fluorometric reader (37 C), with excitation/emission wave-
lengths of 380/440 nm. The proteasome inhibitor MG132
was used as a positive control for proteasome activity
inhibition.
2.11. Isobaric tag for relative and absolute quantitation
(iTRAQ)-based proteomics labeling
Cells were plated, allowed to stabilize for 12 h and incubated
with EEF concentration corresponding to IC50 (113 lg/mL)
for 24 h. Cells were harvested and resuspended in HEPES-
EDTA buffer (50 mM HEPES, 1 mM EDTA, pH 7.4). Then,
the samples were sonicated (3 times for 5 s at 30 lm peak to
peak) in a Vibra Cell sonicator (Sonics & Materials, Inc.) and
centrifuged at 14,000 rpm for 10 min at 4 C to remove cell deb-
ris. The supernatant was collected and protein concentration
was assessed by bicinchoninic acid assay. For iTRAQ-based
quantitative proteomic analysis, 100 lg of protein of each sam-
ple was prepared. The proteins were precipitated with 6 vol-
umes of cold acetone at 20 C overnight and centrifuged for
30 min at 14,000 g. Then, pellets were resuspended with triethy-
lammonium bicarbonate buffer (TEAB) (0.1 M, pH 8.5) and
2% SDS to achieve a final concentration of 0.05%. Samples
were then reduced with 50 mM tris (2-carboxyethyl)
phosphine (TCEP) for 1 h at 37 C. Following this, samples
were alkylated with 10 mM S-methyl methanethiosulfonate
(MMTS) (Sigma-Aldrich) for 10 min at room temperature with
agitation. Trypsin was added to each sample and the digestion
was performed for 18 h at 37 C. Digested sample peptides were
subsequently labeled with the iTRAQ reagent – 8plex
(ABSciex) following the protocol provided by the manufac-
turer. Labels were reconstituted in 60% isopropanol, added
to each sample peptides and incubated for 2 h at room temper-
ature with agitation. The reaction was stopped by adding water
and acidified with formic acid (0.1% final concentration).
Labeled samples were then combined and dried in SpeedVac.
Labeled peptides were separated from an adapted multidi-
mensional liquid chromatography approach, as described by
Vitorino et al. (2012) based on high pH for the first dimension
peptide chromatography with a C18 reverse phase HPLC col-
umn and acidic pH for the second one. Thus, sample loading
was performed at 200 lL/min with buffers (A) 2% ammonium
hydroxide and 0.014% formic acid in water, pH 10 and (B)
2% ammonium hydroxide and 90% acetonitrile (ACN) in
water, pH 10. After 5 min of sample loading and washing, pep-
tide fractionation was performed with linear gradient to 70% B
over 85 min. Sixty fractions were collected, dried in a SpeedVac
and resuspended in 5% ACN and 0.1% trifluoroacetic acid
(TFA). Collected fractions were then separated by LC. Peptides
were loaded onto a C18 pre-column (5 mm particle size, 5 mm;
Dionex) connected to an RP column PepMap100 C18 (150
mm_75 mm i.d., 3 mm particle size). The flow-rate was set atotoxic potential of an ellagitannin-enriched fraction from Fragaria vesca leaves.
Chemical characterization and cytotoxic potential of an ellagitannin-enriched fraction 5300 nl/min. The mobile phases A and B were 2% ACN and
0.05% TFA in water, and 90% ACN with 0.045% TFA in
water, respectively. The gradient started at 10 min and ramped
to 60% B till 50 min and 100% B at 55 min and retained at
100% B till 65 min. The separation was monitored at 214 nm
using a UV detector (Dionex/LC Packings). Using the micro-
collector Probot (Dionex/LC Packings) and, after a lag time
of 15 min, peptides eluting from the capillary column were
mixed with a continuous flow of alpha-CHCA matrix solution
(in internal standard Glu-Fib) and were directly deposited onto
the LC-MALDI plates. The spectra were generated and pro-
cessed with 4800 MALDI-TOF/TOF. Protein identification
based on MS/MS data was performed with ProteinPilotTM soft-
ware (v.4.0, ABSciex) using Paragon search method. SwissProt
from homo sapiens (release date 06022013) was used as protein
database. Default search parameters used were as follows: tryp-
sin as the digestion enzyme, carbamidomethyl modification on
cysteine residue and iTRAQ 8-plex. Bias correction was applied
and proteins were identified with a confidence level of 95%. Pro-
teins were found to be differentially expressed when p< 0.05
(FDR-corrected).
2.12. Statistical analysis
The results are expressed as mean ± standard error of the
mean (SEM). Data were analyzed using one-way analysis of
variance (ANOVA), followed by Dunnett’s post-hoc test. The
differences between the means were considered significant for
values of p< 0.05. The statistical analysis was performed
using Prism 5.0 Software (GraphPad Software).
3. Results and discussion
3.1. Phytochemical characterization of EEF
HPLC-PDA phenolic profile was recorded at 280 nm (Fig. 1)
and 12 compounds were tentatively identified by HPLC-Figure 1 HPLC polyphenolic profile of EEF recorded at 28
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acteristic UV and MS spectra. All these compounds exhibit a
characteristic UV spectrum with maximum absorbance below
270 nm such as those referred by Arapitsas (2012). Almost
all compounds presented a maximum at 248–257 nm with a
slight shoulder between 280 and 284 nm, a characteristic UV
spectral profile that has been referred as a slope (Hanhineva
et al., 2008).
Particular fragmentation patterns are described as follows:
Peak 1 showed a [MH] ion at m/z 965 and the fragmenta-
tion originated a third order ion that matches with ellagic acid
(m/z 301). Hanhineva et al. (2008) found similar molecules on
stamens of Fragaria ananassa flowers, however the ellagitannin
structure was not elucidated yet (Supplementary Fig. 1).
Peaks 2 and 6 were identified as sanguiin H-10 isomers.
Peak 2 presented a [M2H]2 at m/z 783 and peak 6 evidenced
a [MH] ion at m/z 1567, giving a molecular mass of 1568.
The fragmentation patterns were slightly different. Peak 2
originated a most intense MS2 ion at m/z 633 (corresponding
to one galloyl-HHDP-glucose unit) and MS3 ion at m/z 301
(loss of galloyl-glucose residue), whereas peak 6 displayed
a main MS2 ion at m/z 1265 (loss of HHDP unit), MS3 ion
at m/z 935 (loss of galloyl-glucose residue), and MS4 ions at
m/z 633 (loss of other HHDP unit) and 301 (HHDP unit,
corresponding to a loss of HHDP-galloyl-glucose) (Mullen
et al., 2003).
Peaks 3 and 5 evidenced a [MH] ion at m/z 933, MS2
fragments at m/z 451 from the cleavage of tri-galloyl unit
and spontaneous lactonization, 631 from the loss of HHDP
unit and 301 which corresponds to ellagic acid residue. These
compounds were tentatively identified as isomers of
vescalagin/castalagin (Simirgiotis and Schmeda-Hirschmann,
2010).
Peaks 4 and 7 were identified, according to Kool et al.
(2010), as sanguiin H-2 and presented a mono charged molec-
ular ion at m/z 1103. The fragmentation pattern of peaks 4 and
7 was similar in MS2, however the most intense fragments dif-0 nm. The identification of the peaks is shown in Table 1.
otoxic potential of an ellagitannin-enriched fraction from Fragaria vesca leaves.
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loss of CO2 and trihydroxybenzene) and 1059 (44 amu, a loss
of CO2), respectively. In MS
3, the parent MS2 ion at m/z 935
(peak 4) produced ions at m/z 633 (302 amu, a loss of
HHDP) and 301 (302 and 332 amu, a loss of HHDP and
of galloyl-glucosyl moieties respectively), while the parent
MS2 ion of peak 7, at m/z 1059, gave a main fragment
at m/z 935 (124 amu, loss of trihydroxybenzene) and the ions
at 897 (162 amu, a loss of glucosyl moiety) and 633 (44,
124 and 302 amu, a loss of CO2, trihydroxybenzene and
HHDP moieties).
Peaks 8 and 9 were identified as the isomeric forms
of casuarictin or potentillin and presented a molecular ion
at m/z 935 and MS2 main fragments at m/z 633 (302 amu)
corresponding to one galloyl-HHDP-glucose unit and the
ion at m/z 301 originated from lactonization of fragment 302
(Hanhineva et al., 2008). In the MS3 the fragments at m/z
463 and 301 suggest the successive loss of the galloyl and
galloylglucose residues.
Peak 10 is the major compound of this fraction and was
also the main component of the crude extract. It showed a
[MH] ion at m/z 1869 and MS2 ions at m/z 1567 (loss of
an HHDP unit), 1265 (loss of bis-HHDP), 1085 (loss of bis-
HHDP-glucose) and 935, the main fragment, corresponding
to one galloyl-bis-glucose unit. This fragmentation matched
with sanguiin H-6/agrimoniin/lambertianin A isomers, previ-
ously identified in the leaves of Fragaria species (Simirgiotis
and Schmeda-Hirschmann, 2010). The third and fourth orders
of fragmentation pattern confirmed the identification as evi-
denced, respectively by ions at m/z 633 (935  302 amu, loss
of HHDP unit) and 301 (633  332, loss of galloyl-glucose
residue).
Peak 11 displayed a [MH] ion at m/z 1117, giving a
molecular mass of 1118. The structure of this molecule was
not fully elucidated. However, the fragmentation pattern is
consistent with an ellagitannin as evidenced by the main
MS2 ion at m/z 935 (corresponding to a galloyl-bis-HHDP-
glucose), MS3 ion at m/z 633 (loss of HHDP) and MS4
at m/z 301 (loss of galloyl-glucose residue) (Supplementary
Fig. 2).
Peak 12 presented a [M2H]2 at m/z 1009, giving a molec-
ular mass of 2020 Da, and MS2 fragments at m/z 1717, 1567,
1235, 1085, 1065, 935, 897, 783 and 451 (Supplementary
Fig. 3). An ellagitannin with the same molecular mass and a
similar fragmentation pattern was also previously reported in
Fragaria spp (Gasperotti et al., 2013).
Several ellagitannins identified in the EEF were also previ-
ously disclosed in strawberries (Gasperotti et al., 2013;
Simirgiotis and Schmeda-Hirschmann, 2010; Vrhovsek et al.,
2012) – fruits well-known for their anticarcinogenic, antioxi-
dant and genoprotective properties (reviewed in Giampieri
et al., 2012). The major peak of the fraction, identified as san-
guiin H-6, agrimoniin or lambertianin A isomer, was also the
major compound of the crude extract. Although there are still
few studies with the isolated molecules, the anticancer activities
of these proposed compounds were previously addressed in
other cells. For example, it was demonstrated that agrimoniin
induces apoptosis in human gastric cancer cells (SGC-7901)
(Wang and Jin, 2011) and sanguiin-H6 isolated from black-
berry seeds extracts protects the DNA of human lymphocytes
(Godevac et al., 2011). These results suggest the importance
of the ellagitannins as anticancer natural molecules.otoxic potential of an ellagitannin-enriched fraction from Fragaria vesca leaves.
Chemical characterization and cytotoxic potential of an ellagitannin-enriched fraction 73.2. Effect of F. vesca leaves crude extract and EEF on cell
viability
Once identified the compounds present in the EEF we pro-
ceeded to evaluate the biologic effects of this fraction on
HepG2 cells. We started to determinate the IC50 for cell viabil-
ity of both, the EEF and the crude extract of F. vesca leaves.Please cite this article in press as: Liberal, J. et al., Chemical characterization and cyt
Arabian Journal of Chemistry (2015), http://dx.doi.org/10.1016/j.arabjc.2015.11.014Resazurin reduction colorimetric assay was used to assess
the cell viability after 24 h of treatment with increasing concen-
trations of the extract and fraction (up to 10,000 lg/mL). In
order to determine cell sensitivity to treatments, data points
of the dose-response curves were fitted with a sigmoid function
for the calculation of the IC50 values. Data showed that both
treatments reduce cell viability in a dose-dependent manner
as represented in Fig. 2A. In fact, the IC50 of EEF was 6 times
lower (113 ± 1 lg/mL) than the IC50 of the crude extract (690
± 1 lg/mL), suggesting that ellagitannins could be responsible
for the cytostatic/cytotoxic effect of the extract. Based on the
high effect of the fraction relatively to the extract, all the sub-
sequent experiments were performed only with EEF. Since
ellagitannins yield ellagic acid on neutral and alkaline condi-
tions (Daniel et al., 1991; Ross et al., 2007) it would be con-
ceivable that ellagitannins hydrolysis could occur in the
culture medium, thus generating ellagic acid that could be
responsible for the antiproliferative effect of EEF. However,
the absence of any effect on cell viability after cells treatment
with concentrations up to 250 lg/mL of ellagic acid (data
not shown) led us to suggest that cytotoxic effects could be
ascribed to ellagitannins.
3.3. Cell cycle and cell proliferation after treatment with EEF
Defects in cell cycle checkpoints are associated with an uncon-
trolled cellular proliferation and, as such, targeting cell cycle
could be an important strategy for cancer therapy. To further
investigate alterations in the cell cycle of HepG2 cells exposed
to EEF we used flow cytometry.
Cells were incubated with different concentrations of EEF
during 24 h (IC50 = 113 lg/mL; IC45 = 80 lg/mL; IC40 = 56
lg/mL; IC25 = 23 lg/mL; IC15 = 9 lg/mL) and subsequently
analyzed for the distribution of G0/G1, S and G2/M phases.
EEF was able to interfere with cell cycle distribution, being the
effect dependent on the concentrations used. In fact, higher con-
centrations of the EEF clearly induced an increase in cells in the
G2/M phase whereas lower doses promoted a significant
increase in cells in G1 when compared to control cells
(Fig. 2B). Since tumor cells commonly adapt to toxic insults
and recover over time we further evaluated whether EEF effects
are sustainedover time.For that, cellswere treatedwith the same3
Figure 2 Effect of EEF on HepG2 viability, cell cycle and cell
proliferation. (A) Evaluation of cell viability after incubation with
different concentrations of the extract or EEF for 24 h. Data-
points correspond to the mean ± standard deviation of at least
three independent assays performed in duplicate. The IC50 values
were fitted to a sigmoidal function from the dose-response curves.
(B) Cell cycle distribution of cells treated with different concen-
trations of EEF for 24 h. Data are expressed as percentage of PI-
positive cells and are given as the means ± SEM of at least three
independent experiments. (C) EDU incorporation after the
treatment with different concentrations of EEF. Data represent
the mean ± SEM percentage of EDU-labeled cells from three
independent experiments (*p< 0.05, **p< 0.01, ***p< 0.001,
****p< 0.0001 when compared to control; the symbols *, #, $,
* were used for G1, S, G2/M and EDU, respectively).
otoxic potential of an ellagitannin-enriched fraction from Fragaria vesca leaves.
8 J. Liberal et al.concentrations of EEF for 48 h and a markedly G2/M cell cycle
arrest was disclosed for the three higher concentrations tested
(Supplementary Fig. 4). We may therefore point out that the
inhibition of cell proliferation by EEF occurs, at least in part,
through cell cycle arrest in G2/M phases.
We further evaluated HepG2 cell proliferation by the incor-
poration of EDU, determined by flow cytometry, after 24 h of
EEF treatment. The results presented in Fig. 2C show that the
incorporation of EDU is decreased for all the concentrations
studied in a dose-dependent way, thus confirming and support-
ing the previous described effects on cell cycle.
As far as we know, the effect of the ellagitannins herein ten-
tatively identified on cell cycle was never addressed. However,
others ellagitannins were reported to modulate cell cycle distri-
bution and cell cycle regulators, such as casuarinin (Kuo et al.,
2005a, 2005b) and geraniin (Vassallo et al., 2013).Figure 3 Detection of apoptosis/necrosis after EEF treatment. Cells
Annexin V-FITC/PI labeling was detected by FACSCalibur flow cytom
PI negative), late apoptotic cells (annexin V positive/PI positive), necro
negative/PI negative) were evaluated as a percentage of total cells a
experiments (*p< 0.05, **p< 0.01, ***p< 0.001 when compared to c
respectively). (B) Evaluation of morphology of cells stained with May-G
visualized at 40 and 100magnification. (C) Evaluation of nuclear m
fluorescent microscopy at 40 magnification. Arrowheads show nucle
Please cite this article in press as: Liberal, J. et al., Chemical characterization and cyt
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In order to evaluate cell death and to discriminate between
apoptosis and necrosis triggered by the EEF treatment, cells
were incubated with different concentrations of EEF for 24 h
and then stained with annexin V-FITC/PI. The two higher
concentrations of EEF promoted an increase in necrotic cells
(annexin V-negative/PI-positive cells). This increase was
accompanied by a rise, although not statistically significant,
of annexin V-positive/PI-positive cells that correspond to late
apoptotic/necrotic cells (Fig. 3A). To further clarify the mech-
anism of cell death, changes in cell morphology were evaluated
through May-Grunwald-Giemsa staining. Cells treated with
EEF for 24 h showed both features of necrosis (swelling, loss
of membrane integrity) and apoptosis (membrane bleeding
and cell shrinkage), with a predominance of a necrotic cellwere incubated with different concentrations of EEF for 24 h. (A)
eter. The populations of early apoptotic cells (annexin V-positive/
tic cells (annexin V negative/PI positive) and viable cells (annexin V
nd are given as the means ± SEM of at least three independent
ontrol; the symbols * and # were used for viable and necrotic cells
runwald-Giemsa and observed under light microscopy. Cells were
orphology of cells stained with Hoechst 33258 and visualized under
ar swelling.
otoxic potential of an ellagitannin-enriched fraction from Fragaria vesca leaves.
Chemical characterization and cytotoxic potential of an ellagitannin-enriched fraction 9death (Fig. 3B). Furthermore, nuclear morphology of HepG2
cells was assessed with Hoechst 33258. The results indicated
that most of the nuclei are similar to those of control. Never-
theless, larger nuclei that could be related to necrotic cell death
were occasionally observed (Fig. 3C).
Previous studies indicated that ellagitannins induce apop-
totic cell death in in vitro and in vivo models (Wang et al.,
2014; Li et al., 2013). Therefore, it was expected that cells end
up dying by apoptosis. However, we did not detect an increase
in apoptotic cells, neither through the analysis with PI, nor with
annexin V/PI experiment and although the May-Grunwald-
Giemsa staining allowed the visualization of apoptotic cells,
necrosis was clearly the predominant mechanism of cell death.
Accordingly, several studies demonstrated that the induction of
apoptotic cell death evoked by ellagitannins was accompanied
by an increase of necrosis (Cho et al., 2015; Kasimsetty et al.,
2010). Importantly, while initially described as a nonregulated
mechanism of death, necrosis is currently considered a conse-
quence of the crosstalk between several biochemical and molec-
ular events (Festjens et al., 2006). Necrosis occurs in both
physiological and pathophysiological processes and in contrast
to apoptosis, typically promotes an inflammatory response,Figure 4 Effect of EEF on ubiquitin-proteasome system. Chymotryps
for 6 (A) and 24 h (B). Data are presented as mean ± SEM of, at lea
control; Ubiquitinated proteins after incubation with EEF for 24 h w
(P4D1). A representative immunoblot (C) and densitometric quantific
mean ± SEM of 4 independent experiments and are expressed a
****p< 0.0001 when compared to control).
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Arabian Journal of Chemistry (2015), http://dx.doi.org/10.1016/j.arabjc.2015.11.014which may contribute for the tumor regression. On the other
hand, during tumor development, the inflammation due to
the excessive spontaneous necrosis may stimulate the growth
and aggressiveness of the tumor (Proskuryakov and Gabai,
2010).3.5. EEF effect on the cellular proteolytic mechanisms
Our previous data established that F. vesca leaves crude extract
modulates chymotrypsin-like activity of proteasome and
autophagy (Liberal et al., 2014). Consequently, in this work
we sought to evaluate whether the EEF displays similar
bioactivity.
Cells were treated with different concentrations of EEF and
the proteasome inhibitor MG132 was used as control. EEF sig-
nificantly decreased chymotrypsin-like activity of the 26S pro-
teasome after 6 and 24 h of treatment in a dose-dependent
way (Fig. 4A and B, respectively). A decrease in proteasome
degradation would lead to an accumulation of polyubiquiti-
nated proteins. Accordingly, for the highest EEF concentra-
tions tested during 24 h, an accumulation of ubiquitinatedin-like activity of the 26S proteasome of cells treated with the EEF
st, 3 independent experiments and are expressed as percentage of
ere evaluated by western blot using an antibody against ubiquitin
ation of the whole lanes are presented (D). Data are presented as
s percentage of control (*p< 0.05, **p< 0.01, ***p< 0.001,
otoxic potential of an ellagitannin-enriched fraction from Fragaria vesca leaves.
10 J. Liberal et al.proteins was disclosed, suggesting an impairment of protea-
some degradation (Fig. 4C and D), thus corroborating the pre-
vious results.
To evaluate whether EEF affects macroautophagy, we eval-
uated the levels of LC3-II after 6 h of treatment. The conjuga-
tion of LC3-I with phosphatidylethanolamine in the
autophagic membranes leads to the formation of LC3-II,
which is usually used as a measure of autophagosomes number
and, at a certain point, constitutes a reliable marker of autop-
hagic activity. However, besides the increase in autophago-
somes formation, the increased amounts of LC3-II may also
reflect the blockage of autophagosomes fusion with the lyso-
some (Klionsky et al., 2012), thus leading to an accumulation
of these structures. Our data clearly demonstrate that EEF
increased the expression of LC3-II in a dose-dependent way
(Fig. 5) but, to further clarify the molecular mechanism behind
autophagy modulation by EEF, we used chloroquine to mea-
sure the autophagic flux. Chloroquine is an inhibitor of autop-
hagy that raises the lysosomal pH leading to the blockage of
the fusion between autophagosomes and lysosomes and to
the inhibition of lysosomal enzymes, thus decreasing protein
degradation (Klionsky et al., 2012). As expected, cells treated
with chloroquine elicited an accumulation of LC3-II. If the
EEF was able to increase basal autophagy, cells co-incubated
with chloroquine should present higher levels of LC3-II than
cells treated with chloroquine alone. However, data show that
the levels of LC3-II of cells treated with chloroquine or co-
treated with EEF were similar (Fig. 5), suggesting that the
effect of EEF on autophagy relies on the inhibition of
autophagosomes degradation. Still, the mechanism underlying
such effects needs further clarification, in order to understand
how EEF impairs the autophagic clearance.
Recent studies demonstrated that polyphenols have a dual
effect on autophagy, acting as either activators or inhibitors
and it is widely accepted that an up-regulation of autophagy
is beneficial in preventing aging and age-related diseases
(Pallauf and Rimbach, 2013). However, given the dependenceFigure 5 Effect of EEF on autophagy. Cells were treated with
EEF alone or co-treated with chloroquine. A representative
immunoblot is shown above the graph. Data are presented as
mean ± SEM of, at least, 3 independent experiments and are
expressed as percentage of control (*p< 0.01, ****p< 0.0001
when compared to control).
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this proteolytic pathway can promote the survival of cancer
cells (Degenhardt et al., 2006). Accordingly, the inhibition of
autophagy or the combination of autophagy inhibitors with
anticancer agents has been proposed as a therapeutic strategy
in cancer therapy (Amaravadi, 2009).
Regarding ellagitannins, there is very few information about
the potential of these compounds to modulate the clearance
mechanisms of the cells. To the best of our knowledge ellagitan-
nins have not been reported as proteasome inhibitors, although
their precursor, pentagalloylglucose, demonstrated anticancer
effects through proteasome inhibition (Kuo et al., 2009) and
ellagic acid was shown to inhibit 26S proteasome activity
(Chang et al., 2013). Additionally, ellagic acid inhibited autop-
hagy in ovarian cancer cells (Chung et al., 2013), while the ellag-
itannin punicalagin was able to induce autophagy in human
glioma cells (Wang et al., 2013).
3.6. Identification of differentially expressed proteins in EEF-
treated HepG2 cells
To further unveil other molecular targets of EEF, we evaluated
changes induced by EEF in the proteome of HepG2 cells. For
this purpose, we performed a comparative proteomics study
using iTRAQ in cells incubated in the presence or absence of
EEF (113 lg/mL for 24 h). Overall, this approach allowed
the identification of 914 proteins, being 133 differentially
expressed in EEF-treated cells (Fig. 6) (Supplementary
Table 1). Looking at the biological processes and according
to PANTHER classification system, those proteins are
involved in metabolic pathways (39.5%), in cellular (18.4%)
and developmental (7.9%) processes and also in cellular com-
ponent organization or biogenesis (12.3%) (Fig. 7A).
A protein interaction networkwas generated with Cytoscape
(ClueGO plugin), allowing the identification of proteins and
biological processes which are either up- or down-regulated
by EEF (Fig. 7B). The major clusters of interacting proteins
are related to the regulation of translational elongation, de novo
post-translational protein folding and several metabolic pro-
cesses, as NADPH regeneration and glycolysis. It was also
observed a down-regulation of several proteasome subunits,
namely proteasome subunits alpha type-1 and -4, beta type -4
and 26S protease regulatory subunit 4, which are implicated
in the regulation of cellular amine metabolic process, thus cor-
roborating the inhibition of proteasome function, previously
detected (Fig. 7B). The most significant cluster – cell metabo-
lism,mainly covers the protein, nuclease-containing compound,
carbohydrate and lipid metabolic processes. It is well estab-
lished that cancer cells have altered metabolism, enabling its
rapid proliferation and continuous growth (DeBerardinis
et al., 2008). Hence, drugs that perturb cancer cell metabolism
may open a perspective in cancer treatment.
Two of the most differently expressed proteins (FAS and
IGFBP1) were chosen to validate the iTRAQ experiment by
western blot. Besides the concentration used in proteomic
experiments, lower concentrations were also tested in order to
check whether the effects are dose-dependent. The results con-
firmed that EEF decreased FAS (Fig. 8A) and increased
IGFBP1 (Fig. 8B), being those effects dependent on EEF con-
centration. IGFBPs interact with insulin-growth factors (IGF)
I-II limiting their bioavailability. Since increased levels of insu-otoxic potential of an ellagitannin-enriched fraction from Fragaria vesca leaves.
Figure 6 Log ratio comparison of the relative intensity for the significantly regulated proteins (EEF/Control).
Chemical characterization and cytotoxic potential of an ellagitannin-enriched fraction 11lin and IGF have been linked to cancer progression (Yu, 2000),
F. vesca leaves and particularly its EEF may be an important
source of molecules able to disturb cancer cells metabolism
and therefore represent an attractive therapeutic strategy forPlease cite this article in press as: Liberal, J. et al., Chemical characterization and cyt
Arabian Journal of Chemistry (2015), http://dx.doi.org/10.1016/j.arabjc.2015.11.014cancer. Increased fatty acid biosynthesis is also characteristic
of cancer cells. FAS is a key enzyme for de novo fatty acid syn-
thesis, catalyzing the conversion of acetyl-CoA and malonyl-
CoA to palmitic acid. It was reported that enhanced FASotoxic potential of an ellagitannin-enriched fraction from Fragaria vesca leaves.
Figure 7 Effect of EEF on HepG2 proteome. (A) Distribution of differentially regulated proteins according to biological processes
based on gene ontology annotation, after cells treatment with EEF. (B) Protein–protein interaction network generated with Cytoscape.
Green nodes represent upregulated proteins while red nodes demonstrate downregulated proteins after 24 h of treatment with EEF.
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Figure 8 Effect of EEF on FAS and IGFBP1 protein levels. HepG2 cells were incubated with different concentrations of EEF fraction
for 24 h and FAS (A) and IGFBP1 (B) protein levels were evaluated by western blot. Data are presented as mean ± SEM of, at least, 3
independent experiments and are expressed as percentage of control (*p< 0.05, **p< 0.01 when compared to control). Representative
immunoblots are presented above the graphs.
Chemical characterization and cytotoxic potential of an ellagitannin-enriched fraction 13expression and activity confer both growth and survival advan-
tages in human tumors, including the hepatocellular carcinoma
(Hao et al., 2014), being considered a metabolic oncogene.
Moreover, several FAS inhibitors had shown antitumor activ-
ity, such as cerulenin (Pizer et al., 1996), the plant derived
polyphenol curcumin (Fan et al., 2014) and epigallocatechin
gallate (Brusselmans et al., 2003). In this work, we showed that
EEF decreases FAS protein expression in a hepatocellular car-
cinoma cell line. Accordingly, Liu et al. (2009) reported that sev-
eral ellagitannins were strong inhibitors of FAS activity. Taken
together, ellagitannins might be potential anticancer molecules
through the inhibition of FAS expression and activity.4. Conclusion
The potential of polyphenols for cancer therapeutics has gained
increased attention in the last years. Particularly, ellagitannins have
been indicated as antiproliferative, antiangiogenic and pro-apoptotic
compounds. In this study the phenolic characterization of an
ellagitannin-enriched fraction from F. vesca leaves was performed.
This fraction was more active than the crude extract in inhibiting
HepG2 cell viability. Additionally, EEF also decreased cell prolifera-
tion, and induced the cell cycle arrest in G2/M. Our previous results
strongly suggested that autophagy was modulated by the crude extract
of F. vesca leaves. Herein, we demonstrated that EEF impairs autop-
hagic flux, possibly leading to the cytoplasmic accumulation of
autophagosomes that are not efficiently degraded. Along with the inhi-
bition of autophagy, EEF also promoted the accumulation of ubiqui-
tinated proteins, inhibited chymotrypsin-like activity of 26S
proteasome and decreased the expression of several proteasome sub-
units, indicating an impairment of UPS degradation.
Furthermore, the proteomic analysis allowed the identification of
differentially expressed proteins from several functional clusters, pri-
marily affecting metabolic processes.
Overall, several cellular and molecular targets of EEF, and most
probably of ellagitannins, were unveiled, suggesting that these com-
pounds could be potential therapeutic agents against hepatocellular
carcinoma. However, future studies should be considered in order to
dissect the effect of EEF isolated compounds and also to investigate
the synergism between ellagitannins and conventional chemotherapeu-
tic agents.Please cite this article in press as: Liberal, J. et al., Chemical characterization and cyt
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